CHRISTINE MUMEY: Open Payments
NPI 1295234300 · SALEM, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,359 in 60 payments from 28 companies in 2025. Trend: 2023 $982 · 2024 $609 · 2025 $1,359
Food & beverage: $1,264Education: $95
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 15 | $192 |
| Merck Sharp & Dohme LLC | 4 | $104 |
| Janssen Scientific Affairs, LLC | 1 | $101 |
| SEAGEN INC. | 1 | $95 |
| BeOne Medicines USA, Inc. | 3 | $76 |
| Janssen Biotech, Inc. | 3 | $75 |
| GlaxoSmithKline, LLC. | 3 | $66 |
| ABBVIE INC. | 3 | $65 |
| GENZYME CORPORATION | 2 | $52 |
| AstraZeneca Pharmaceuticals LP | 2 | $51 |
Products named: DARZALEX, BRUKINSA, KEYTRUDA, SARCLISA, IBRANCE, VENCLEXTA, ZYNLONTA, XTANDI.
Industry payments across OR — which companies pay providers there.
